皮下注射左甲状腺素治疗难治性原发性甲状腺功能减退:一例病例报告
本病例报告评估了皮下注射左甲状腺素在一位51岁男性患者中的有效性,该患者曾因乳头状甲状腺癌行全甲状腺切除术,后因包裹性硬化性腹膜炎导致甲状腺素吸收不良和蛋白结合甲状腺素肠道丢失,TSH恶化至>100 mIU/L。皮下注射左甲状腺素以100 mcg每周三次的低剂量起始,药代动力学吸收研究显示皮下给药后6小时游离甲状腺素增加103%,相对生物利用度为口服的8.75倍,TSH在20天后恢复正常。
要点
- 皮下左甲状腺素可能为口服吸收不良患者提供替代给药途径。
- 药代动力学研究显示皮下左甲状腺素相对生物利用度为口服的8.75倍。
- 本例中皮下左甲状腺素100 mcg每周三次使TSH在20天内恢复正常。
核心结论
- 皮下左甲状腺素可能作为口服吸收不良患者的替代治疗选择。
研究设计与样本
- 病例报告:一名51岁男性,因乳头状甲状腺癌行全甲状腺切除术后,因包裹性硬化性腹膜炎导致甲状腺素吸收不良,TSH>100 mIU/L。
主要发现
- 皮下注射左甲状腺素100 mcg后6小时游离甲状腺素增加103%。
- 药时曲线下面积分析显示皮下左甲状腺素相对生物利用度为口服左甲状腺素的8.75倍。
- 皮下左甲状腺素起始剂量为100 mcg每周三次,TSH在20天后恢复正常。
临床怎么用
- 对于口服左甲状腺素吸收不良的难治性原发性甲状腺功能减退患者,可考虑皮下注射左甲状腺素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We assessed the effectiveness of administering subcutaneous levothyroxine in a medically complex patient, a 51-year-old male who previously underwent total thyroidectomy for papillary thyroid carcinoma. His thyrotropin (TSH) worsened to >100 mIU/L, caused by encapsulating sclerosing peritonitis that led to thyroxine malabsorption and enteral loss of protein-bound thyroxine. Several routes of levothyroxine were evaluated prior to subcutaneous levothyroxine. METHODS: Subcutaneous levothyroxine was initiated at a low dose of 100 mcg thrice a week. A pharmacokinetic absorption study was performed to assess the bioavailability of subcutaneous levothyroxine against oral levothyroxine. RESULTS: A 103% increase in free thyroxine at 6 hours post-subcutaneous levothyroxine 100 mcg confirmed effective absorption. Area-under-curve analysis showed that the relative bioavailability of subcutaneous levothyroxine was 8.75 times of oral levothyroxine for our patient. Hence, subcutaneous levothyroxine was initiated, with TSH normalizing 20 days later. CONCLUSIONS: Subcutaneous levothyroxine may be an alternative in patients with oral malabsorption.
引用
- Law LS, Kuu NWX, Leong MHT, et al. Subcutaneous Levothyroxine Administration in Treatment of Refractory Primary Hypothyroidism: A Case Report. Thyroid. 2025. PMID: 41467917. doi:10.1177/10507256251409071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。